Publicaciones en las que colabora con Juan Manuel Irache Garreta (62)

2024

  1. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab

    Drug Delivery and Translational Research, Vol. 14, Núm. 5, pp. 1189-1205

  2. Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles

    Frontiers in Immunology, Vol. 15

2022

  1. Effect of topical berberine in murine cutaneous leishmaniasis lesions

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 4, pp. 1072-1081

2021

  1. 3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice

    Acta Tropica, Vol. 215

  2. Changes in the nanoparticle uptake and distribution caused by an intramacrophagic parasitic infection

    Nanoscale, Vol. 13, Núm. 41, pp. 17486-17503

  3. Human serum albumin as a potential nanocarrier for the oral delivery of therapeutic proteins

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 15-17

  4. Nanoparticles from Gantrez-based conjugates for the oral delivery of camptothecin

    International Journal of Pharmaceutics: X, Vol. 3

  5. Oral Efficacy of a Diselenide Compound Loaded in Nanostructured Lipid Carriers in a Murine Model of Visceral Leishmaniasis

    ACS Infectious Diseases, Vol. 7, Núm. 12, pp. 3197-3209

2020

  1. Berberine-loaded liposomes for the treatment of leishmania infantum-infected balb/c mice

    Pharmaceutics, Vol. 12, Núm. 9, pp. 1-18

2019

  1. Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions

    Pharmaceutics, Vol. 11, Núm. 11

  2. Nanoparticles from Gantrez® AN-poly(ethylene glycol) conjugates as carriers for oral delivery of docetaxel

    International Journal of Pharmaceutics, Vol. 571

2018

  1. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions

    Journal of Dermatological Science, Vol. 92, Núm. 1, pp. 78-88

  2. Pegylated poly(anhydride) nanoparticles for oral delivery of docetaxel

    European Journal of Pharmaceutical Sciences, Vol. 118, pp. 165-175

2017

  1. A combination of nanosystems for the delivery of cancer chemoimmunotherapeutic combinations: 1-Methyltryptophan nanocrystals and paclitaxel nanoparticles

    Pharmacological Research, Vol. 126, pp. 77-83

  2. Skin vaccination using microneedles coated with a plasmid DNA cocktail encoding nucleosomal histones of Leishmania spp.

    International Journal of Pharmaceutics, Vol. 533, Núm. 1, pp. 236-244

2016

  1. Oral delivery of camptothecin using cyclodextrin/poly(anhydride) nanoparticles

    International Journal of Pharmaceutics, Vol. 506, Núm. 1-2, pp. 116-128

2015

  1. Assessment of β-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB/c mice

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 11, Núm. 8, pp. 2003-2012

  2. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles

    Journal of Pharmaceutical Sciences, Vol. 104, Núm. 9, pp. 2877-2886

2014

  1. Co-encapsulated CpG oligodeoxynucleotides and ovalbumin in PLGA microparticles; an in vitro and in vivo study

    Journal of Pharmacy and Pharmaceutical Sciences, Vol. 17, Núm. 4, pp. 541-553

  2. Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis

    Expert Opinion on Drug Delivery, Vol. 11, Núm. 4, pp. 579-597